Automate Your Wheel Strategy on CNC
With Tiblio's Option Bot, you can configure your own wheel strategy including CNC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CNC
- Rev/Share 361.0388
- Book/Share 55.7251
- PB 0.6426
- Debt/Equity 0.6414
- CurrentRatio 1.0979
- ROIC 0.0295
- MktCap 17523625440.0
- FreeCF/Share 2.1882
- PFCF 16.2256
- PE 8.5734
- Debt/Assets 0.2034
- DivYield 0
- ROE 0.0753
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | CNC | Cantor Fitzgerald | Overweight | Neutral | -- | $38 | July 28, 2025 |
| Downgrade | CNC | Wells Fargo | Overweight | Equal Weight | -- | $30 | July 23, 2025 |
| Downgrade | CNC | TD Cowen | Buy | Hold | -- | $33 | July 21, 2025 |
| Downgrade | CNC | BofA Securities | Neutral | Underperform | -- | $30 | July 16, 2025 |
| Downgrade | CNC | Morgan Stanley | Overweight | Equal Weight | -- | $33 | July 10, 2025 |
| Downgrade | CNC | JP Morgan | Overweight | Neutral | -- | $48 | July 2, 2025 |
| Downgrade | CNC | UBS | Buy | Neutral | -- | $45 | July 2, 2025 |
| Resumed | CNC | Morgan Stanley | -- | Overweight | -- | $70 | June 9, 2025 |
| Downgrade | CNC | Barclays | Overweight | Equal Weight | -- | $65 | June 2, 2025 |
| Upgrade | CNC | Jefferies | Underperform | Hold | -- | $64 | April 8, 2025 |
News
Centene Corporation (CNC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: July 29, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , July 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Centene Corporation ("Centene" or the "Company") (NYSE: CNC). IF YOU SUFFERED A LOSS ON YOUR CENTENE INVESTMENTS, CLICK HERE BEFORE SEPTEMBER 8, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
Read More
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene
Published: July 29, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Centene To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Centene between December 12, 2024 and June 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 29, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Centene Corporation ("Centene" or …
Read More
Superior HealthPlan and Centene Foundation Announce Grand Opening of CHDI Multi-Purpose Community Health Center in Uvalde
Published: July 28, 2025 by: PRNewsWire
Sentiment: Neutral
The $16 million center is managed by Community Health Development, Inc., and offers healthcare services, community support, and other resources UVALDE, Texas , July 28, 2025 /PRNewswire/ -- Superior HealthPlan and the Centene Foundation, the philanthropic arm of Centene (NYSE: CNC), today joined Community Health Development, Inc. (CHDI) to open a new $16 million multi-purpose community health center in Uvalde. The 16,000-square-foot space provides healthcare services, community support and outreach, education and workforce development, and a meeting space for the Uvalde community and the surrounding region.
Read More
Centene's Bottom May Already Be Here - Risk Mitigation In Process
Published: July 28, 2025 by: Seeking Alpha
Sentiment: Positive
CNC has offered FY2025 adj EPS range at between $1.25 (-82.5% YoY) and $1.75 (-75.5% YoY), as medical costs rise drastically and higher morbidity sign-ups replace a healthier base. These have directly triggered the drastically lower consensus forward estimates, with the healthcare providers expected to report impacted, new normal profit margins. Despite so, readers must note that CNC is already engaging on risk mitigation while driving improved profitability through rate adjustments from 2026 onwards.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Centene Corporation of Class Action Lawsuit and Upcoming Deadlines - CNC
Published: July 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation (“Centene” or the “Company”)(NYSE: CNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
CNC Investors Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit with the Schall Law Firm
Published: July 28, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , July 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 12, 2024 and June 30, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before September 8, 2025.
Read More
Centene's Worst Quarter In Years Could Be A Gift
Published: July 28, 2025 by: Seeking Alpha
Sentiment: Positive
Centene's Q2 results were ugly but better than feared, with losses largely expected and a visible path to recovery emerging. Management is aggressively addressing ACA and Medicaid margin pressures, with rate adjustments and reratings expected to restore profitability by 2026. Valuation remains highly attractive, trading at under 7x PE, offering potential for the stock to double as earnings rebound and multiples normalize.
Read More
Time To Buy Centene Stock?
Published: July 28, 2025 by: Forbes
Sentiment: Negative
Centene (NYSE:CNC) recently reported a surprise loss of $0.16 per share for Q2, significantly missing analyst expectations of $0.23 per share. This downturn is primarily attributed to a continued increase in medical costs for government-backed insurance plans, evidenced by a 540 basis point year-over-year surge in its health benefit ratio to 93% in Q2.
Read More
Centene raises Wall Street optimism that Medicaid insurers can improve profits
Published: July 25, 2025 by: Reuters
Sentiment: Positive
Wall Street regained confidence in Medicaid insurers after Centene said on Friday it expects to be able to raise rates charged to states for 2026 health plans for low-income Americans and strengthen profit margins.
Read More
Centene Stock Up 5% After First Loss In 13 Years, Bullish Guidance
Published: July 25, 2025 by: Forbes
Sentiment: Positive
Shares of Centene -- a St. Louis-based managed-care company offering services through Medicaid, Affordable Care Act plans and Medicare – have been on a roller coaster.
Read More
Centene Corporation (CNC) Q2 2025 Earnings Call Transcript
Published: July 25, 2025 by: Seeking Alpha
Sentiment: Neutral
Centene Corporation (NYSE:CNC ) Q2 2025 Earnings Conference Call July 25, 2025 8:30 AM ET Company Participants a - Corporate Participant v - Corporate Participant Andrew Lynn Asher - Chief Financial Officer Jennifer Lynch Gilligan - Senior Vice President of Investor Relations Sarah M. London - CEO & Director Conference Call Participants Albert J.
Read More
Medical Expenses Erode Centene's Bottom Line in Rare Q2 Earnings Miss
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Negative
CNC reports rare Q2 loss amid surging medical costs, lower investment and other income despite strong revenue growth.
Read More
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene
Published: July 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Centene To Contact Him Directly To Discuss Their Options
Read More
Centene Stock Showing Signs of Life After Revenue Beat
Published: July 25, 2025 by: Schaeffers Research
Sentiment: Positive
Centene Corp (NYSE:CNC) stock is 3.9% higher to trade at $27.75 this morning, even after the managed healthcare company reported an adjusted second-quarter loss of 16 cents per share, steeper than the 11 cents per share projected.
Read More
Centene: Pricing In Complete Obliteration
Published: July 25, 2025 by: Seeking Alpha
Sentiment: Positive
Managed care insurance is at record pessimism, with Centene trading at decade-low valuations, creating a potential generational buying opportunity. Regulatory headwinds, rising medical costs, and bearish industry data have led to guidance withdrawal and significant EPS reductions for Centene. Centene is responding by repricing plans for 2026 and focusing on cost controls, while Medicare Advantage and Prescription Drug segments outperform expectations.
Read More
Centene stock plunges after surprise loss and soaring medical costs
Published: July 25, 2025 by: Invezz
Sentiment: Negative
Shares of Centene Corp. dropped sharply on Friday morning after the health insurer reported a surprise quarterly loss, driven by rising medical costs and a significantly higher-than-expected health benefits ratio. The results underscored the mounting challenges facing the health insurance industry, which has been grappling with elevated care utilization and regulatory uncertainty.
Read More
Deadline Alert: Centene Corporation (CNC) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Published: July 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, July 24, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 to June 30, 2025, inclusive (the “Class Period”).
Read More
Will Escalating Medical Costs Dampen Centene's Q2 Earnings?
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Negative
CNC's Q2 earnings are likely to have felt the pinch as rising medical costs pressure margins despite higher premium revenues.
Read More
Centene Corporation (CNC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: July 23, 2025 by: PRNewsWire
Sentiment: Neutral
BENSALEM, Pa. , July 23, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Read More
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene
Published: July 23, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Centene To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Centene between December 12, 2024 and June 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Centene Corporation ("Centene" or …
Read More
Centene Corporation Class Action: Levi & Korsinsky Reminds Centene Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 8, 2025 – CNC
Published: July 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.
Read More
Unveiling Centene (CNC) Q2 Outlook: Wall Street Estimates for Key Metrics
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
Evaluate the expected performance of Centene (CNC) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Centene Corporation of Class Action Lawsuit and Upcoming Deadlines - CNC
Published: July 22, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , July 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation ("Centene" or the "Company")(NYSE: CNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Read More
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Centene Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CNC
Published: July 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”), of the important September 8, 2025 lead plaintiff deadline.
Read More
Centene Corporation (CNC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: July 21, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , July 21, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Centene Corporation ("Centene" or the "Company") (NYSE: CNC) have opportunity to lead the securities fraud class action lawsuit.
Read More
CNC Investors Have Opportunity to Join Centene Corporation Fraud Investigation with the Schall Law Firm
Published: July 21, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , July 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Centene Corporation(CNC) Shareholders
Published: July 21, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , July 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Centene Corporation (NYSE: CNC). Shareholders who purchased shares of CNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Read More
CENTENE CORPORATION (NYSE: CNC) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Centene Corporation Investors of Upcoming Deadline
Published: July 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?
Read More
Centene Corporation Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - CNC
Published: July 21, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , July 21, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.
Read More
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene
Published: July 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Centene To Contact Him Directly To Discuss Their Options
Read More
About Centene Corporation (CNC)
- IPO Date 2001-12-13
- Website https://www.centene.com
- Industry Medical - Healthcare Plans
- CEO Sarah M. London
- Employees 60400